| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-13 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.47 | 5e-12 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-12 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.45 | 3e-11 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |